NEW YORK (GenomeWeb News) – Molecular diagnostics firm AdvanDx today announced it submitted a 510(k) application to the US Food and Drug Administration for clearance of its mecA XpressFISH test for the rapid detection of methicillin-resistant Staphylococcus aureus from S. aureus-positive blood cultures.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.